4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-002257
CEO and CFO bought 1,500 shares at $17.37 ($26,055)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-01-20 | Purchase | +1,500 | $17.37 | $26,055 | 2,732,886 | D |
| Open-market purchases · 1,500 sh · avg $17.37 · $26,055 | |||||||
Loading xslF345X03/ownership.xml…